Diabetic neuropathy in children and youth: New and emerging risk factors

Gulcin Akinci1, Masha G Savelieff1, Gary Gallagher1

  • 1Department of Neurology, University of Michigan Medicine, Ann Arbor, Michigan, USA.

Pediatric Diabetes
|November 18, 2020
PubMed

Insights

Diabetic neuropathy is increasing in children due to type 1 and type 2 diabetes, alongside obesity. More research is needed for prevention and management strategies in youth.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Neurology

Background:

  • Diabetic neuropathy is a known complication in youth with type 1 diabetes.
  • Rising rates of obesity and type 2 diabetes are expected to increase pediatric neuropathy incidence.
  • Pathogenic insights and management strategies for pediatric diabetes-related neuropathy remain limited.

Purpose of the Study:

  • To review the current knowledge on neuropathy in children and youth with type 1 and type 2 diabetes.
  • To emphasize prevalence, clinical presentation, diagnostic approaches, and risk factors.
  • To highlight current management strategies and recommendations.

Main Methods:

  • Literature review of adult studies and available youth cohort data.
  • Synthesis of current understanding of diagnostic, management, and preventative measures.
  • Emphasis on prevalence, clinical presentation, diagnostics, risk factors, and management.

Main Results:

  • Neuropathy is a significant complication in youth with diabetes, exacerbated by obesity.
  • Understanding is evolving from adult and youth studies regarding presentation and risk factors.
  • Current management strategies and recommendations are being established.

Conclusions:

  • Addressing the rising incidence of neuropathy in youth with diabetes and obesity requires identifying modifiable risk factors.
  • Randomized controlled trials are crucial to evaluate interventions like weight loss and exercise.
  • Enhanced awareness and early detection are vital for prevention and management.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
740
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
189